» Articles » PMID: 24096697

Selective Anticancer Agents Suppress Aging in Drosophila

Overview
Journal Oncotarget
Specialty Oncology
Date 2013 Oct 8
PMID 24096697
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations of the PI3K, TOR, iNOS, and NF-κB genes increase lifespan of model organisms and reduce the risk of some aging-associated diseases. We studied the effects of inhibitors of PI3K (wortmannin), TOR (rapamycin), iNOS (1400W), NF-κB (pyrrolidin dithiocarbamate and QNZ), and the combined effects of inhibitors: PI3K (wortmannin) and TOR (rapamycin), NF-κB (pyrrolidin dithiocarbamates) and PI3K (wortmannin), NF-κB (pyrrolidine dithiocarbamates) and TOR (rapamycin) on Drosophila melanogaster lifespan and quality of life (locomotor activity and fertility). Our data demonstrate that pharmacological inhibition of PI3K, TOR, NF-κB, and iNOS increases lifespan of Drosophila without decreasing quality of life. The greatest lifespan expanding effect was achieved by a combination of rapamycin (5 μM) and wortmannin (5 μM) (by 23.4%). The bioinformatic analysis (KEGG, REACTOME.PATH, DOLite, and GO.BP) showed the greatest aging-suppressor activity of rapamycin, consistent with experimental data.

Citing Articles

Effects of Target of Rapamycin and Phosphatidylinositol 3-Kinase Inhibitors and Other Autophagy-Related Supplements on Life Span in Male .

Bearden A, Stewart E, Casher C, Shaddix M, Nobles A, Mockett R Int J Mol Sci. 2024; 25(21).

PMID: 39519056 PMC: 11547029. DOI: 10.3390/ijms252111504.


Combinatorial interventions in aging.

Parkhitko A, Filine E, Tatar M Nat Aging. 2023; 3(10):1187-1200.

PMID: 37783817 PMC: 11194689. DOI: 10.1038/s43587-023-00489-9.


Therapeutic Antiaging Strategies.

Mishra S, Balendra V, Esposto J, Obaid A, Maccioni R, Jha N Biomedicines. 2022; 10(10).

PMID: 36289777 PMC: 9599338. DOI: 10.3390/biomedicines10102515.


Molecular mechanisms of exceptional lifespan increase of Drosophila melanogaster with different genotypes after combinations of pro-longevity interventions.

Shaposhnikov M, Guvatova Z, Zemskaya N, Koval L, Schegoleva E, Gorbunova A Commun Biol. 2022; 5(1):566.

PMID: 35681084 PMC: 9184560. DOI: 10.1038/s42003-022-03524-4.


Innate and Adaptive Immunity in Aging and Longevity: The Foundation of Resilience.

Moskalev A, Stambler I, Caruso C Aging Dis. 2020; 11(6):1363-1373.

PMID: 33269094 PMC: 7673842. DOI: 10.14336/AD.2020.0603.


References
1.
Joshi-Tope G, Gillespie M, Vastrik I, DEustachio P, Schmidt E, de Bono B . Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2004; 33(Database issue):D428-32. PMC: 540026. DOI: 10.1093/nar/gki072. View

2.
Helenius M, Hanninen M, Lehtinen S, Salminen A . Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem J. 1996; 318 ( Pt 2):603-8. PMC: 1217663. DOI: 10.1042/bj3180603. View

3.
Libert S . Insights into physiology of aging and novel ways to increase lifespan. Fly (Austin). 2009; 1(2):113-5. DOI: 10.4161/fly.4288. View

4.
Wang C, Li Q, Redden D, Weindruch R, Allison D . Statistical methods for testing effects on "maximum lifespan". Mech Ageing Dev. 2004; 125(9):629-32. DOI: 10.1016/j.mad.2004.07.003. View

5.
Garrett J, Chakrabarty A, Arteaga C . Will PI3K pathway inhibitors be effective as single agents in patients with cancer?. Oncotarget. 2012; 2(12):1314-21. PMC: 3282088. DOI: 10.18632/oncotarget.409. View